Clinical Trials

Status
Published

Recently Activated

SHOW MORE
View
Open
Phase
II
SWOG Clinical Trial Number
CTSU/EA4181

A Randomized 3-Arm Phase II Study Comparing 1.) Bendamustine, Rituximab and High Dose Cytarabine (BR/CR) 2.) Bendamustine, Rituximab, High Dose Cytarabine and Acalabrutinib (BR/CR-A), and 3.) Bendamustine, Rituximab and Acalabrutinib (BR-A) in Patients <= 70 Years Old with Untreated Mantle Cell Lymphoma
Status Notes
Activation - Effective 10/3/19
Research Committee(s)
Lymphoma
Activated
10-03-2019
Open
SWOG Clinical Trial Number
CTSU/A071701

GENOMICALLY-GUIDED TREATMENT TRIAL IN BRAIN METASTASES
Status Notes
Step 0 & Step 1 Activation Effective 8/15/19; SWOG Activation Effective 9/1/19
Research Committee(s)
Brain Cancer
Activated
09-01-2019
ClinicalTrials.gov Registry Number
NCT03994796
Open
Phase
III
SWOG Clinical Trial Number
CTSU/NRG-BR004

A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Status Notes
Activated by NRG Oncology on 3/12/19.
Activated by SWOG: 7/24/2019
Research Committee(s)
Breast Cancer
Activated
07-24-2019
ClinicalTrials.gov Registry Number
NCT03199885
Open
Phase
SWOG Clinical Trial Number
CTSU/A011202

A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Status Notes
ALLIANCE activated: 2/7/14
SWOG activated: 7/24/19
Research Committee(s)
Breast Cancer
Activated
07-24-2019
ClinicalTrials.gov Registry Number
NCT01901094
Open
SWOG Clinical Trial Number
CTSU/A221405

A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women with Endocrine Responsive Breast Cancer who Desire Pregnancy
Status Notes
Alliance activated: 10/15/15
SWOG activated: 7/27/19
Research Committee(s)
Breast Cancer
Activated
07-24-2019
ClinicalTrials.gov Registry Number
NCT02308085
Open
Phase
SWOG Clinical Trial Number
CTSU/EA1131

A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Breast Cancer following Neoadjuvant Chemotherapy
Status Notes
ECOG-ACRIN activated: 4/29/2015
SWOG activated: 7/24/19
Research Committee(s)
Breast Cancer
Activated
07-24-2019
ClinicalTrials.gov Registry Number
NCT02445391